These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31300585)

  • 1. Drug-Induced Hyperpigmentation: Review and Case Series.
    Giménez García RM; Carrasco Molina S
    J Am Board Fam Med; 2019; 32(4):628-638. PubMed ID: 31300585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Update on Drug-Induced Pigmentation.
    Nahhas AF; Braunberger TL; Hamzavi IH
    Am J Clin Dermatol; 2019 Feb; 20(1):75-96. PubMed ID: 30374894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment.
    Dereure O
    Am J Clin Dermatol; 2001; 2(4):253-62. PubMed ID: 11705252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline-Induced Scleral and Dermal Hyperpigmentation.
    Haskes C; Shea M; Imondi D
    Optom Vis Sci; 2017 Mar; 94(3):436-442. PubMed ID: 27870777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of latanoprost-induced diffuse facial skin hyperpigmentation.
    Kim HY; Lee SK; Lee JH; Suh JH; Kim MS; Lee UH
    J Cosmet Dermatol; 2019 Dec; 18(6):1717-1720. PubMed ID: 30924263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
    Sibaud V; Fricain JC; Baran R; Robert C
    Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine-induced hyperpigmentation.
    Bicknell LM; McFaddin CL; Fernandez M; Parekh P
    Cutis; 2017 Sep; 100(3):E8-E10. PubMed ID: 29121138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An 80-year old man with a bluish-grey facial coloration].
    Gülderen I; Koushk-Jalali B; Kreuter A
    Dtsch Med Wochenschr; 2021 Apr; 146(7):479-480. PubMed ID: 33780996
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation.
    Leyden J; Wallo W
    Int J Dermatol; 2011 Apr; 50(4):470-7. PubMed ID: 21332714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed-induced hyperpigmentation of the skin.
    Schallier D; Decoster L; de Greve J
    Anticancer Res; 2011 May; 31(5):1753-5. PubMed ID: 21617235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous hyperpigmentation during therapy with hydroxychloroquine.
    Amichai B; Gat A; Grunwald MH
    J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546
    [No Abstract]   [Full Text] [Related]  

  • 13. Serpentine supravenous hyperpigmentation induced by chemotherapy: a systematic review.
    Shan J; Obiakor BC; Cheng J; Francois RA; Dobry AS
    Arch Dermatol Res; 2024 May; 316(6):215. PubMed ID: 38787426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine-Induced Reversible Pellagroid Skin Lesion.
    Singh LK; Sahu M; Praharaj SK
    Curr Drug Saf; 2015; 10(3):251-3. PubMed ID: 26077832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.
    Tsilika K; Tran A; Trucchi R; Pop S; Anty R; Cardot-Leccia N; Lacour JP; Ortonne JP; Passeron T
    JAMA Dermatol; 2013 Jun; 149(6):675-7. PubMed ID: 23553009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
    Chou SY; Chou CK; Kuang TM; Hsu WM
    Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin adverse effects of amiodarone].
    Zgazarová S; Jedlicková H; Vasků V
    Vnitr Lek; 2009 Oct; 55(10):976-80. PubMed ID: 19947243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral lower extremity induration in a patient with leiomyosarcoma.
    Lee MS; Shi CR; Sauer M; Laga AC; Talia J; Nambudiri VE
    Lancet Oncol; 2021 Oct; 22(10):e466. PubMed ID: 34592196
    [No Abstract]   [Full Text] [Related]  

  • 19. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid.
    Ozog DM; Gogstetter DS; Scott G; Gaspari AA
    Arch Dermatol; 2000 Sep; 136(9):1133-8. PubMed ID: 10987869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latisse-induced periocular skin hyperpigmentation.
    Priluck JC; Fu S
    Arch Ophthalmol; 2010 Jun; 128(6):792-3. PubMed ID: 20547960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.